Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
  • Doubleline Shiller Enhanced Cape DSENX
    Has anyone bought any of the newer Doubleline Funds? I am interested in any thoughts on their new stock funds. I am especially interested in the Shiller Enhanced Cape DSENX. He is basically a bond guy, but he always has something to say about an individual stock, or section of the stock market.
  • Anyone have thoughts on ARLSX performance?
    Well, I think we all realize that if there is one important space in the mix we have yet to fill with a satisfying pick then dis is it. And that makes us needy, and that can lead to reading more into the numbers than is warranted. Hope is not an investment strategy.
    I'm with cman; based on the data, BPLEX is really all we have that comes close to measuring up. Perhaps there are other funds on the current landscape that will prove their worth, and the markets since 2009 have been pretty lousy for most L/S strategies to show this. And so we watch and wait, and not give in?
    And maybe, just maybe, our patience will be rewarded, and something like the Robertson Stevens Global L/S fund of the late 1990s will come along [damn, was that gal good].
  • Dr. Doom
    Hi Guys,
    The most likely answer to Ron’s question about the morphing of Marc Faber from Mr. Doom to Mr. Happy is never. He is committed to his own worldview and the present circumstances and data are nearly irrelevant.
    In the financial community he exhibits all the characteristics of a Mr. No. I use the term Mr. No to conveniently contrast his behavior with a dedicated Mr. Yes. In many circles, adventurer Richard Branson is fondly called Mr. Yes. His most famous saying is “Screw it. Let’s do it”. That aggressive motto has earned him innumerable successes, and an occasional backslide.
    I don’t buy into these pre-judgments, these by-gosh-and-by-golly pre-commitments. I think of them as lazy folly. It sure eases the decision process. Although that’s attractive in many commonplace instances, it can get an investor into deep hot water. Although the markets do reflect a cyclical behavior, each cycle differs from past experience sufficiently to merit a separate review and evaluation.
    The marketplace is far too complex to be modeled by overly simplistic correlations. As Albert Einstein cautioned “Everything Should Be Made as Simple as Possible, But Not Simpler”. Oversimplification introduces the possibility of allowing the really significant market drivers to escape detection.
    Perhaps this is the logic that InvesTech’s Jim Stack uses in his multidimensional set of market direction criteria. He adjusts his portfolio holdings incrementally as the various signals penetrate their threshold levels. I do buy into that conservative multi-criteria approach.
    The last quarter’s GDP growth numbers were dismal. Over the long haul, academic and industry research find zero or nearly zero correlation between market returns and GDP growth values. But more recent and more nuanced studies, that introduced a wider array of independent parameters, suggest otherwise. The more nuanced assessment includes parameters like inflation, policy stance, and interest rates to augment GDP growth rate data.
    Here are Links to a sample of the longer-term GDP growth study data, a GDP growth per capita data set, and the more nuanced findings:
    http://www.businessinsider.com/correlation-between-equity-returns-gdp-growth-2013-11
    http://www.businessinsider.com/equity-returns-and-gdp-per-capita-2014-2
    http://www.schroders.com/staticfiles/schroders/sites/Americas/US Institutional 2011/pdfs/Equity-Returns-and-GDP.pdf
    All of this is good stuff. They might well serve as partial signals to help guide your portfolio asset allocation decisions. I would never suggest that these are decisive by themselves. The issue is much more complex.
    For example, I have always included some measure of the equity markets Price to Earnings ratio (P/E or more recently CAPE) as part of my decision making process. Today, that signal is above its historical average, but it’s been in that dangerous zone for quite some time now. This bit of evidence supports the Faber assertion. At some point he will be proven correct, but who knows the unknowable timetable?
    Today, I’m still into equities at my long-term percentage. But I am getting a little queasy, a little antsy. I’m taking no immediate action. I’m waiting for more evidence, one way or the other. As a general rule, I am not a market timer.
    Stay loose guys. Don’t prejudge like either Faber or Branson. Let the accumulating data and whatever criteria you deploy be your final guide. Good luck to all of us.
    Best Regards.
  • Which bond fund in FIDO?
    Thanks for the advice, all of you. FSICX had escaped my notice. Beats the bogey M* selected for it. Thanks, cman.
    Since FAIGX has 70% equity and costs 1.16%,, I'll just slump back in my rocking chair on the porch, Ted. (Or did you mean FAGIX?)
  • A Better Alpha and Persistency Study

    I really do want Cman to continue his informative postings. I agree with MFOer davidrmoran that his postings are often elliptical, but when decoded with care and when the unsupported proclamations are discarded, the submittals are substance intense and useful.
    Time to conclude with the same deniability of a personal attack against a credible opponent and a repetition of the back handed compliments reinforcing the take away points you started with so the jury leaves with that impression.

    I’m positive that Cman will respond; that’s his nature and it’s fully expected and respected.
    It is also useful to prepare for a rebuttal that you obviously expect for such attacks so next time you can start with my opponent has responded predictably... To imply that it was already expected and considered to diminish the response for the jury. You can do that regardless of what your opponent rebuts with.

    Cman likes to morph simple problems into multilayered complex problems.
    Another useful approach is to try to bait the opponent into an irrational outburst because that always diminishes the opponent's argument. Patronizing statements, back handed compliments, passive aggressive attacks are all good candidates when done carefully so as not to antagonize the jury in the process. May not work against all opponents but works against most.

    Remember the classic WWII submarine movie titled “The Enemy Below”. It starred Robert Mitchum and Curt Jurgens as competing captains. The movie plot revolved around the “if I do this, he’ll do that, but he knows I know that so I’ll alter my tactics, but he’ll anticipate that change, so I’ll …..” endless logic circle.
    In the meantime the adversary escapes, at least momentarily in this film classic. At some point the circle must be broken and a decision must be forthcoming (no action is part of the decision options). Studies have a diminishing returns aspect to them.
    In the investment world, decisions must be made with incomplete information and always with an uncertain future. Further study and delay adds no value. So just do it or not, given a current assessment of the circumstances. I hope my positions on this matter are not elliptical.
    Ending with a reference to popular culture is always a jury awakener that brings them into a blissful state if they can identify with it and focus on it and the repeated take away points and not the manipulative techniques used.
    It is also useful to slip in the mischaracterization of the opponent for a final take away point. The opponent is only providing a choice between endless loops and action now. This will obfuscate and hide the opponent's constructive suggestion of a study that will more realistically prove or disprove the same claims to replace a flawed evidence. Jury may be excused for losing track of that by this time.

    Best Wishes to everyone, and especially to Cman.
    Always a good idea to end with a gentlemanly and passive aggressive conclusion to obscure the real intent and motivation. :-)
    Look forward to writing the next chapter of the "Illustrated Guide to Lawyering tactics".
    There are still many tools left to use in a lawyer's arsenal to influence the jury such as righteous indignation, befallen misfortunes in getting to the court, Jury nullification, etc. :-)
    I hope @mjg will oblige by providing further illustrative examples.
  • A Better Alpha and Persistency Study
    Hi Guys,
    This post is very difficult for me. It demands a delicate balanced set of thoughts that just might be beyond my competency reach.
    I really like Cman’s submittals. In general I agree with almost 100% of the informational content although I don’t subscribe to his lack of documentation. My admiration ends when he interjects opinions and assertions that are not supported by any analysis or references.
    I believe Cman really tries to educate us. Most of my postings are similarly directed. However, I also think that his posts tend to be pedantic; so do mine. As the old saw goes “It takes one to know one”.
    I know why mine are so oriented. I spent the larger part of my working experience trying to win competitive contracts. If I wasn’t absolutely positive of my positions, I lost the competition. Perhaps Cman faced the same daunting challenge.
    But the Cman and my educational pathways bifurcate at the documentation juncture. Typically, his postings are full of assertions and opinions that are devoid of supportive references, studies, or actual data. It is impossible to judge the merits of these assertions if you are not intimately familiar with the subject matter. I try to be meticulous in this area; hence I’m pedantic.
    Mark Twain was on target when he said that “All generalizations are false, including this one “.
    Given the lack of supportive documentation, a fair observer might conclude that Cman has fallen victim to the behavioral handicap of Overconfidence.
    His judgments are far too rash. He uses pejorative descriptors such as “Junk Science” and “Garbage In, Garbage Out” without describing the junk science elements or the garbage inputs. Garbage Out is an individual reviewer judgment and depends on his personal assessment of the work quality.
    During my college years, I was infrequently exposed to “the proof is assigned to the student” charge. I hated that assignment then, and I still dislike it today, especially in the investment world. My interpretation: That assignment either comes from a lazy educator or one that is not confident in his own knowledge or capabilities.
    Acting as an educator, Cman often fairly presents both sides of an issue. That’s great, although there are limitations. President Harry Truman detested two-handed economists. He particularly despised the “On the one hand this” and “On the other hand that” type of advice. He pleaded for a one-handed economist who proffered a plain decision.
    Denials notwithstanding, Cman and really all MFOers do have a pony in the active-passive race. Costs and results do matter to everyone. The debate is NOT a done deal. Claiming an early closure is equivalent to proclaiming a victory while the battle is still raging. That mostly works to an opponent’s advantage.
    No standalone active-passive fund management study is conclusive by itself. The issue has far too many dimensions to permit a single, all-inclusive analysis to address and to resolve all the multitude of issues. Since no universal investment Ironclad laws exist, all studies are empirical in nature. All models are simplifications of reality; hopefully they still capture the governing elements of that reality. They are all imperfect.
    Selecting bias free data and study timeframes will always influence findings. That’s specifically why numerous studies are needed and will continue to yield more realistic insights. The MIG study fits into that grouping.
    I believe the MIG team did an honest job. I even think they were somewhat surprised by their findings. I’m nudged in that direction by the way they presented their findings. Their very first table shows that 4 of their 6 major fund categories delivered positive Alpha before costs. But nobody invests without costs.
    In the same paragraph, MIG adjusts for costs and concludes that : “When comparing the median outperformance to the median fee for each asset class, the gross outperformance of the median manager has not justified the historical median fee. In other words, it seems that in the asset classes where active managers have added value, the median level of fees negated any advantage.”
    Cman emphasized the “no cost” result to the detriment of the overarching negative Alpha after fees conclusion. That’s a little disingenuous, especially if you proclaim to have no ponies in the race.
    Yet Cman elects to destroy the credibility of MIG’s efforts with ad hominem attack words like Junk Science and GIGO. All research is subject to errors ranging from incomplete data collection to poor practices to flawed data interpretations. But an honest attack requires full documentation, not merely shaky comprehensive assertions.
    It is not at all clear why MIG would have incentives to prepare a defective report since their reputation is at risk. They do have much skin in the game.
    The MIG team that Cman so firmly criticized has over 600 billion dollars under management, has been in the consulting business since 1978, and has recently been awarded a competitively bid contract from the California State Teachers’ Retirement System (CalSTRS). I’m sure they have been on the wrong side of some investment advice, but so has everyone else. As a minimum, MIG has demonstrated staying power.
    I really do want Cman to continue his informative postings. I agree with MFOer davidrmoran that his postings are often elliptical, but when decoded with care and when the unsupported proclamations are discarded, the submittals are substance intense and useful.
    I’m positive that Cman will respond; that’s his nature and it’s fully expected and respected. Cman likes to morph simple problems into multilayered complex problems. Remember the classic WWII submarine movie titled “The Enemy Below”. It starred Robert Mitchum and Curt Jurgens as competing captains. The movie plot revolved around the “if I do this, he’ll do that, but he knows I know that so I’ll alter my tactics, but he’ll anticipate that change, so I’ll …..” endless logic circle.
    In the meantime the adversary escapes, at least momentarily in this film classic. At some point the circle must be broken and a decision must be forthcoming (no action is part of the decision options). Studies have a diminishing returns aspect to them.
    In the investment world, decisions must be made with incomplete information and always with an uncertain future. Further study and delay adds no value. So just do it or not, given a current assessment of the circumstances. I hope my positions on this matter are not elliptical.
    Best Wishes to everyone, and especially to Cman.
  • A Better Alpha and Persistency Study
    Hi mrdarcy,
    I appreciate your extra effort to secure a copy of Professor Kaushik’s report.
    I suspect you and I are in substantial agreement that study findings are always tightly coupled to its methodology. Details just don’t simply matter, they matter greatly, and can reverse conclusions. In reviewing all research work, one conundrum is to identify which studies are of sufficiently high quality to accurately reflect the real world marketplace.
    Even with our current shortfall with regard to some details of Kaushik’s procedures and data qualifying techniques, it is clear that his data preferences depart from those used by S&P and by the MIG organization.
    For example, Kaushik used Morningstar as his primary data source for the small cap category; MIG used the Russell 1000 Value category benchmark. S&P typically accesses the University of Chicago CRSP data. By itself, the data source benchmark can invert conclusions. Here is a Link to a fine summary paper, “Lessons Learned from SPIVA”, generated by the Journal of Indexes that supports that observation:
    http://www.etf.com/publications/journalofindexes/joi-articles/11140-lessons-learned-from-spiva.html
    I direct your attention specifically to Lesson 6, Benchmark Choice Matters in the Active-Passive Debate. In this instance for Small Caps, the active managers outperformed its Russell 2000 benchmark by a smidgen for the time period considered, but active managers underperformed when measured against the S&P Small Cap 600 standard.
    The referenced article has a wealth of actionable conclusions. Please access it.
    The S&P summary review and the earlier mentioned MIG report both document that any active fund management excess returns is very time dependent, and erode as the timeframe expands. Managers enjoy momentary success, but that success crumbles to negative integrated outcomes relative to a benchmark. The referenced S&P paper also addresses this issue.
    Persistent positive Alpha performance escapes all but a few active managers. The most devastating illustration of that overarching conclusion is provided as the Manager 5-year Persistence graph near the end of the MIG report. No trend-line, no pattern is discernable; it is a shotgun blast.
    As stressed previously, the MIG release provides superb charting evidence of active managers volatile performance relative to their benchmarks. Indeed, active management can enhance outcomes, but they also can substantially detract. Subtraction is hard to take. This time dependent data is included as Appendix C in the MIG paper.
    Since we are focusing on Small Cap results, please examine the chart titled “Russell 1000 Value”; it is located on page 20 of the report. It depicts aggregate SCV active manager outcomes measured against their benchmark. The data is displayed from 1979 to 2012. Note the random and spiky nature of the curve, and that it shows mostly negative relative performance years.
    Also note that the SCV curve had a respectable positive bump in the 1999-2002 and the 2007-2009 timeframes. These were the glory years for active managers in that fund category. That glory has faded recently. The persistency handicap strikes once again. It’s a tough marketplace for active fund management.
    I find the empirical evidence undeniable. Sure some active managers will outdistance their benchmark during short periods. But that advantage is ephemeral for almost all survivors.
    In their 2012 SPIVA report, S&P concludes that “The annual league tables over the past 10 years demonstrate that short-term outcomes (such as one-year performance figures) of the index versus active debate are less consistent than longer-term outcomes.” Some things remain fairly stable. For completeness, here is the Link to that S&P document:
    http://www.spindices.com/documents/spiva/spiva-us-year-end-2012.pdf
    I never tell folks how to invest; that’s always their personal choice. However, I have no qualms about presenting them with the relevant statistics. It is their job to weigh the odds and the expected excess Alpha potential.
    It is a daunting task to identify consistent fund manager winners. Perhaps dedicated and well informed mutual fund buyers can discover a glittering gem in the treacherous terrain. Good luck to them, and even to myself since I plan to do a little of that dubious exploration.
    Best Wishes and Happy Easter.
  • Any Mebane Faber fans here (hint: free books)
    Just finished his book Global Value (Kindle for PC).
    I was impressed with the book.
    He says that the U.S. stock market is the most overvalued stock market in the world now, based on the CAPE ratio. The CAPE for the U.S. is roughly 25.
    He says that at a minimum, we should have 50% of our equities outside the U.S., since that is a market cap weighting. But.....a global GDP weighting would only have 20-40% of the equities as U.S. stocks.
    However, to have an equity allocation aligned with the theme of his book, he states: "Similarly, ponder a value approach to your equity allocation. Consider overweighting the cheapest countries and avoiding the most expensive ones. Currently, this would mean a low, or zero, allocation to US stocks. Note: This does not mean simply picking one or two countries, but rather a basket of the cheapest countries – 10 is a reasonable number."
    Looks like his Cambria Global Value, GVAL would accomplish that.
  • GMO: A CAPE Crusader--- A Defence Against The Dark Art
    @Ted. Really good!
    At heart of ragging debate these days, seems like.
    Been going on for a while now...since probably 2011 until November. Resumed in 2012. And, of course, all the CAPE_Crusaders would have missed 2013 run up in US stock market, if they had timed their allocation based on P/E valuations.
    I suspect CAPE_Crusaders would argue P/E valuation predictions are longer-term, based on following five-ten year returns. So, 2013 is just a blip here.
    Another thing is that looking back at all the P/E plots, like Exhibit 1 below from Mr. Montier's paper, there have been many continuous years of "inflated" P/Es, like 50-60s and 80-90s. Would really hate to miss those years.
    image
    That said, though we've had pull backs, it's been a while since we had sustained period of "cheap" P/E, like the painful '70.
    The conclusion then from all these folks is low expectations for real returns in foreseeable future, as summarized in GMO's latest forecast. (Site requires registration, but it is free...and void of pop-ups, etc...I highly recommend it.)
  • Any Mebane Faber fans here (hint: free books)
    Yes, very interesting. And it seems that Mebane Faber is doing something that John Templeton used to do, that is, find undervalued stock markets around the world. Robert Shiller was on WealthTrack a few weeks ago, and said that he invested in I believe it was Italy this year, based on the stock market in Italy being very cheap based on the CAPE. Seems to be in some sense the global application of the principles of Ben Graham.
  • Old_Skeet's Take ... Along with supporting reference links.
    Hi MarkM,
    Thank you for your rapid response.
    My overarching takeaway from your various replies is that you have discovered the magic elixir that permits a respectable estimate of market-wide FMV, at least one focused on longer-term projections. Even given your stated reservations, such a discovery deserves a substantial Wow exclamation. That’s an impressive accomplishment that warrants attention.
    A reliable and reasonably accurate FMV methodology has eluded even the very best individual minds (guys of the caliber of Benjamin Graham and his student Warren Buffett) and institutional entities (Vanguard, JP Morgan, Morningstar) for decades. Congratulations.
    Again from your posting, I realize that you have been hampered by some difficulties in fully implementing the approach. For example you stated that: “Frankly, its hard as hell to adopt this approach when the market moves away from you and hard as hell again when markets fall and there seems to be no good reason to place money at risk!” and later “Long term it works but is very difficult to execute.”
    I’m puzzled by these comments. They certainly are suggestive of significant holes in your approach given these limitations. Also, why the procedure would be “difficult to execute “ totally escapes me. Could the mathematics be that gory? I doubt it. Most investors, including a high percentage of professional wizards, are actually mathematically phobic.
    Additionally, it is worrisome that your FMV signal has a “momentum concession” given that you use it as a longer term forecasting tool. Momentum is a dissipative force. I’m uncomfortable with any momentum adjustment that is purportedly operative a decade into the future. Market momentum effects usually disappear in less than 3 years.
    Your reservations seem to point to a highly idiosyncratic technique. I hope it is not that individual and distinctive. If it is so, I understand your unwillingness to discuss any of its details whatsoever. It offers little value to MFO members or an even wider audience.
    Under these circumstances I would be circumspect about anticipating successful applications in the future. These types of formulations that have benefited from heavily restricted success have a dismal persistency record and are hazardous as projection tools. Professionals relearn this hard lesson time and time again.
    However, if you judge the approach to not be idiosyncratic, I strongly urge you to consider formally documenting it. You could be “Famous by Friday” as California tennis coach Vic Braden often proclaimed. The investment world needs a semi-reliable 10-year forecasting tool. History will remember you if you develop such a tool.
    I would not simply reveal the method specifics on this fine website. MFO has too limited a membership. Rather, I suggest you submit an outline to a respected financial and/or business journal. If accepted after peer review, your accomplishment will be widely circulated, enthusiastically received, and your contribution firmly acknowledged for all time.
    Regardless of the present state of your still undefined, mysterious approach, and its general application, I wish you well in your forecasting efforts. If what you do is too complex or conditionally fragile, I would likely choose not to deploy it for my purposes. Everyone chooses their own investment poison.
    I am a satisfied member of the simplicity is better cohort. That philosophy keeps my costs low, permits me to stay the course under challenging circumstances since I understand my strategy, and allows me to eschew risky investments that test foolish boundaries.
    I wish you continued success and good luck in your future investments and all your financial matters.
    Best Regards.
  • The Biotech Bubble: Is It Or Isn't It ?
    Scott,Maybe a lot of investors saw your video post!Thanks for your timely takes on
    investment opps and current trends and long term ideas.
    Aeropostale -12.3% AH on FQ4 miss, guidance, $150M financing deal
    Aeropostale (ARO) is guiding for FQ1 EPS of -$0.70 to -$0.75, well below a -$0.17 consensus. The forecast doesn't account for expected consulting fees or "potential accelerated store closures."
    The apparel retailer has obtained $150M worth of credit facilities - a 5-year, $100M term loan facility, and a 10-year, $50M term loan facility - from P-E firm Sycamore Partners.
    The deal includes an apparel sourcing arrangement with Sycamore-affiliated MGF Sourcing, and also gives Sycamore preferred stock good for buying 5% Aeropostale's common stock at a price of $7.25. If converted, the shares would raise Sycamore's stake to 12.3%.
    Aeropostale was previously reported to be weighing investment and sale options. The company ended FQ4 with $106.5M in cash/equivalents, and no debt.
    Aeropostale now plans to close 52 stores in FY14 (ends Jan. '15), while opening 7 and remodeling 10. The FY14 capex budget has been lowered to $22M from $35M; FY13 capex was $84M.
    Comparable sales (inc. e-commerce) fell 15% Y/Y in FQ4, the same as FQ3. Gross margin fell 680 bps Y/Y to 13%
  • Process and Luck over Outcome
    Hi Vert,
    Thank you for investing your valuable time to respond to my post. Alternate viewpoints are always welcomed, encouraged, and respected. It’s how a vibrant marketplace works its price discovery magic.
    I have never met either Warren Buffett or Benjamin Graham. So my insights into their investment concepts come either from their personal writings, their direct quotes, and/or financial writers interpretations of their perceived wisdom. Certainly my own personal investing proclivities, education, and style influence the manner in which I translate and interpret these various sources. Others will surely internalize divergent takeaways from these same word sources.
    I’m very happy that you took time to express your personal opinions. I suspect that you and I will never quite see eye-to-eye on this matter, but that's okay by any standards. Thirty years ago I was a solely active investor. Most recently I decided that passive Index investing offers the likelihood, never the guarantee, of superior portfolio rewards. Therefore, without completely abandoning active fund management, I decided to weight my portfolio much more heavily in the Index direction.
    I admire the pugnaciousness and tenacity of active investors. With total disregard for their own efficiency, that cohort makes the overall marketplace a more efficient world with their constant trading. Passive investors gain the advantages of the efficient market without paying the casino croupier. I plan to take full advantage of this almost free lunch. I wish all these energetic active investors the best of luck.
    I do insist that I reported the quotes from Mauboussin and Graham without either error or omission. I did not do selective pruning to distort or misrepresent their positions on these important matters.
    I like Michael Mauboussin for his multi-discipline investment approach and his explanatory clarity. I do not see the verbal contradictions that you observed. To paraphrase, he said that by concentrating on good process, the likelihood of good results is improved, but without guarantees since outcomes are uncontrollable.
    I do not doubt that self-generated contradictions exist. Over time, everyone makes statements that are not totally consistent. I surely do. Warren Buffett has and continues to do so. It is a human failing. I accept these minor inconsistencies and push ahead.
    Speaking of Buffett, his current shareholders letter supports many of the insights referenced by Mauboussin and Graham as quoted in my initial posting. Here are two extended extractions from that shareholders letter as summarized in the Motley Fool website:
    On the simplest, best investment strategy for individual investors: "My money, I should add, is where my mouth is: What I advise here is essentially identical to certain instructions I've laid out in my will. ... My advice to the trustee could not be more simple: Put 10% of the cash in short-term government bonds and 90% in a very low-cost S&P 500 index fund. (I suggest Vanguard's.) I believe the trust's long-term results from this policy will be superior to those attained by most investors -- whether pension funds, institutions or individuals -- who employ high-fee managers."
    And,
    On avoiding market (mis)timing: "The 'when' [of investing] is also important. The main danger is that the timid or beginning investor will enter the market at a time of extreme exuberance and then become disillusioned when paper losses occur. (Remember the late Barton Biggs' observation: "A bull market is like sex. It feels best just before it ends.") The antidote to that kind of mistiming is for an investor to accumulate shares over a long period and never to sell when the news is bad and stocks are well off their highs. Following those rules, the 'know-nothing' investor who both diversifies and keeps his costs minimal is virtually certain to get satisfactory results.”
    This complete Motley Fool summary is titled “25 Must-Read Quotes from Buffett’s Letter to Shareholders” and is authored by Alex Dumortier. Here is the Link to the entire review:
    http://www.fool.com/investing/general/2014/03/08/25-must-read-quotes-from-buffetts-letter-to-shareh.aspx
    The investing principles advocated by both Benjamin Graham and his student Warren Buffett have certainly changed over time. Those changes are most likely the result of better informed marketplace participation groups (now mostly smart institutional investors). Although it is often credited to John Maynard Keynes, it is more likely that Professor Paul Samuelson said: “Well when events change, I change my mind. What do you do?”
    The Graham extended quote that I referenced was just such a reevaluation of the investor environment and opportunities in the early 1970s. The job of identifying underpriced stocks was simply becoming harder.
    I’m a bit bemused how your interpretation of that paragraph differs so dramatically from mine. You ignore the consistent thrust throughout the paragraph and glom onto the innocuous phrase “To that very limited extent" as a salient part that describes his mistrust of passive Index investing. I disagree.
    That escape clause was added to simply acknowledge that some investors are superstars and do outperform market average returns. Certainly his students did for years, and when he made those comments, Graham was with a group of these investors. Graham was merely recognizing that the marketplace was more efficient and that finding exceptional undervalued stocks (his cigar butt one-puff theory) was probably beyond the capabilities of most, but not all, investors. This was an unexpected eureka moment in his life that must have shocked Buffett.
    The fundamental meaning of the referenced paragraph is abundantly clear: excess returns are more difficult to find. It is definitely not an amateur’s (average investors) game.
    I enjoyed your perspective on these topics and thank you again for your thoughtful contribution.
    Best Wishes.
  • Thoughts on Wintergreen Fund
    Wintergreen 2013 Annual Report:
    Dear Fellow Wintergreen Fund (Trades, Portfolio) Shareholder,
    2013 seemed to be the year when the quality, valuations, and risks of businesses ceased to matter to most stock market participants. The Standard & Poor's 500 Composite Index ("S&P 500 (INDEXSP:.INX)") remarkable rise for the year was its best return since 1997 during the run-up of the technology bubble. The ten best performing names in the S&P 500 had extremely high returns, while carrying an average price-to-earnings multiple of 58. Among these top performers were a struggling retailer (Best Buy Co., Inc. (NYSE:BBY)), a recently bankrupt airline (Delta Air Lines, Inc. (NYSE:DAL)), a brokerage still digging itself out from the finanacial crisis (E TRADE Financial Corporation (NASDAQ:ETFC)), a biotechnology company (Celgene Corporation (NASDAQ:CELG)), and two poster children of a potential new internet bubble (Netflix, Inc. (NASDAQ:NFLX) and Facebook Inc (NASDAQ:FB)). We believe the extraordinary returns on securities we view as highly speculative names are a microcosm of the broader market in 2013 - market participants moving down the quality spectrum in search of returns, without regard for and understanding of risks and valuations. We believe overseas securities languished and emerging markets became the scapegoat of popular opinion.The widespread appetite for risk has been fueled in part by years of artificially low interest rates in most developed markets around the world. When safe high-quality assets yield a fraction of one percent, it isn't surprising to see many investors flock to high-risk, high-reward investments, be it junk bonds or speculative equities. This is exemplified by high-yield bond spreads approaching historical lows, sub-prime mortgages being bid up 17% in the past year, and speculative equities posting triple-digit gains. Classic fundamental analysis of business values, a keystone in true investing, was replaced with an insatiable desire for returns at any cost and often a failure to acknowledge the inherent risk of many investment vehicles.
    There is a popular Wall Street notion that momentum trading (i.e., buying stocks that have recently risen in price solely because they have recently risen in price) allows someone to hop from trend to trend as if they are a surfer riding the crest of a wave, and that this will enable one to trade their way to wealth. This "quick and easy" approach to speculating, which has been sold to investors in a relentless media blitz accompanying the latest bull market, is seldom successful in the long-run. More often, people don't get just wet, but financially soaked.
    http://www.wintergreenfund.com/downloads/wintergreen_fund_annual_report_20131231.pdf
  • The Battle For Alternative Mutual Funds
    FYI:
    Regards,
    Ted
    Copy & Paste Barron's 2/22/14: Beverly Goodman
    Noted investment manager KKR caused a bit of a stir earlier this month when it announced it will close two of its entrants into the mutual fund arena.
    It's not that the funds themselves were so notable. In fact, they're about to be shuttered because they failed to get any traction in the year they were open. But it speaks to the difficulty of the ongoing quest to incorporate alternative investment strategies into a mutual fund format—and who can offer the most elegant solution.
    In the case of KKR's two funds, it seems clear that mutual fund companies had an advantage. KKR is a pre-eminent investment manager, with much more name recognition than the typical hedge fund firm, and yet its mutual funds couldn't compete. It wasn't a matter of performance: The KKR Alternative High Yield fund (ticker: KHYKX) returned more than 7% last year, beating the category average, but the firm acknowledged in a statement that the fund simply had too many established competitors (a "very crowded marketplace") with long track records. The KKR Alternative Corporate Opportunities fund (XKCPX) returned 14% in 2013, but was an overly complicated hybrid product that came with an onerous initial-investment process and "lacks the daily liquidity most mutual fund investors expect." Both funds in about a year took in just $33 million, on top of KKR's $125 million in seed money.
    And yet investors appear to be clamoring for alternative-investment strategies in a mutual fund structure. Hedge funds saw $6.9 billion in outflows last year, while liquid alternative mutual funds took in $40 billion, according to Morningstar data. And that category doesn't include fixed income: Another $55 billion went into unconstrained or nontraditional bond funds, the mutual fund answer to fixed-income and credit hedge funds. With some $360 billion in assets, hedge funds still dwarf the $139 billion in alternative mutual funds—but may not for long.
    Many alternative managers, however, are now realizing that their investment expertise isn't enough to make them successful among retail investors. "Mutual fund firms are just better at navigating the landscape and understanding the business," says Josh Charney, an alternative-investment analyst with Morningstar, adding, "They've been marketing products since the dawn of time. Hedge funds have only been allowed to market since the JOBS Act went into effect."
    Indeed, the big winners have been offerings from mutual fund firms. Long/short equity funds took in $20.5 billion last year, though the lion's share, $13.4 billion, went into just one fund—the $21 billion MainStay Marketfield fund (MFLDX), which saw its assets triple. It returned 16.9% last year, versus 14.6% for the long/short category. Performance helped, certainly, but MainStay is a part of New York Life, which has a 150-person sales force. "We don't even think of Marketfield as an alternative fund," says Steve Fisher, president of MainStay Funds. "It's just a mutual fund with a very flexible approach. Our distribution model helps advisors understand how our funds fit into a portfolio."
    Hedge funds face challenges in reaching mutual fund investors, and developing relationships with their advisors. Mutual fund firms, meanwhile, face challenges in terms of hiring the talent necessary to manage alternative portfolios. Alternative mutual funds often carry a management fee near the 2% charged by most hedge funds, but they're not allowed to pay managers a portion of the gains—making it a much less lucrative opportunity for the manager.
    RATHER THAN A PITCHED BATTLE between alternative managers and fund companies, though, the approach we're likely to see more of going forward is one of collaboration. Mutual fund firms can use their name recognition and marketing and sales prowess, and rely on the investing expertise of hedge fund managers. Many alternative mutual funds use subadvisors to manage assets. One of the most successful examples is Blackstone's partnership with Fidelity—in terms of both the development and execution of the final product.
    Last August, the two firms launched the Blackstone Alternative Multi-Manager fund (BXMMX); its $1.2 billion in assets is allocated across 12 hedge fund managers including Cerberus, Wellington Management, and Caspian Capital. It's only available to the high-net-worth clients of Fidelity's Portfolio Advisory Services group. It's an exclusive arrangement for one year, but John McCormick, director of Blackstone's alternative asset management group, says the fund's appeal for "mom and pop investors," could also lend itself to inclusion in a 401(k) plan, variable annuity, or other insurance product.
    Blackstone initially approached Fidelity several years ago with an idea for "a very different sort of product," McCormick says. After extensive talks and reworking, the two firms arrived at a fund that could exploit Blackstone's heft in the hedge fund world and Fidelity's reach in the retail world. "We're the largest allocator to hedge funds in the world," McCormick says. "If we ask them to build something special, they do it."
    .
  • Making sense of Marketfield Mainstay Fund Options
    Class P shares are specifically designed to be offered through fund supermarkets:
    Class P shares are only available to investors purchasing shares through a no-load transaction fee network or platform that has entered into an agreement with NYLIFE Distributors LLC, the Fund's principal underwriter and distributor or its affiliates to offer Class P shares through a no-load transaction fee network or platform. Class P shares have no initial or subsequent investment minimums.
    From prospectus.
    Class P shares have a lower ER (no 12b-1 fee) than Class A or Inv shares (A/Inv shares are virtually identical except that A shares typically require a $25K min) both of which come with a load. You can see this difference in the reported one year performance: 16.87% (Class P), vs. 16.62% (Classes A and Inv), reflecting the 0.25%/year 12b-1 fee in the latter. (Figures from NYLife website.)
    For some reason, Mainstay also claims (in the prospecutuses) that the cost the fund incurs for shorting stocks is nearly a full percent lower for P shares than for A shares (1.18% vs. 2.14%). (This difference makes no sense however, and I would suggest further study.)
    Regardless, the absence of a 12b-1 fee, and the absence of a load, makes purchasing P shares through a supermarket cheaper than purchasing load shares (unless you're purchasing over $1M worth, in which case the load is waived).

    At Fidelity
    , you can establish an initial position for $49.95, and then DCA automatically at $5/transaction. You don't escape the commission, but you can keep it pretty low. Other brokerages may offer DCA for even less (or zero).
  • celebrating one-starness
    Reply to @AndyJ:
    Hi AndyJ,
    Thank you for reading and replying to my post.
    I do believe that most MFO participants are somewhat immune to the attraction of the Star ratings. But not all are, and most of the general pubic blindly fall under its spell. Most investing folks find it hard to resist. As unlikely as it seems, a measurable segment of our population still believes in Astrology.
    I had the good fortune to become familiar with Morningstar in its formative years. I enjoyed frequent exchanges with John Rekenthaler during this period. The Morningstar team were true believers that they had invented a winning formula, and they touted it with high confidence. For the uniformed investor, for the novice investor, for the lazy investor , and especially for the investor susceptible to advertisement, the Morningstar star system became the de facto bible.
    All behavioral research concludes that folks have a propensity to make decisions with the reactive (system 1) portion of their brain rather than the reflective (system 2) segment. We’re lazy and often default to an easily recalled Star rating when making a mutual fund decision.
    The tsunami of Star advertising, mostly funded by the mutual funds themselves, sealed the deal by constantly proclaiming the wonders of their 5-star and 4-star funds. They failed to mention the highly ephemeral nature of these ratings.
    The tidal wave of misleading advertisements that extolled the virtues of the Star system motivated the 1990s research that challenged its usefulness as a predictive tool. Yes, Morningstar did admit the limitations of its service, and did modify it. My reference to Russ Kinnel documents that conversion and acknowledgement. But the general investor population still trusts the Star ratings, often to the exclusion of other more dominant factors (like costs).
    Please see MFOer BobC’s professional comments on this topic. It dovetails precisely with my amateur’s observations. A lot of investors still slavishly subscribe to the Star ratings. The loyalty persists and can do significant harm to portfolio maintenance like encouraging more frequent fund tradeoffs.
    BobC sees it in his daily interactions with clients. I see it through the continuing attention given to it in research projects. That’s why I referenced the 2010 Vanguard study. Professor Bill Sharpe challenged the utility of the Star program in the late 1990s; Vanguard considered it a topic worthy of research dollars in 2010, a decade later. The issue perseveres.
    Uninformed, or rookie, or lazy, or advertisement susceptible investors still make investment decisions using primarily, and perhaps singularly, Star ratings. That’s troublesome. It inspired my posting. The Star trap is hard to escape.
    I know you haven’t fallen victim to it. I trust that most MFO members avoid it, but some do not. My submittal is merely a cautionary reminder. Take care.
    Best Wishes.
  • Burned By Bonds -- Should You Leave ?
    I wonder how many billions will escape PIMCO this year? It doesn't look as though the public is buying the new normal that Gross and El-Erian are peddling.
    Dan Ivascyn hopefully is re-negotiating his contract.